Medical Developments International Limited (ASX: MVP)
Health Care · Pharmaceuticals · AU
AU$0.42
-2.35% today · -38.1% 1Y
Medical Developments International Limited (ASX: MVP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $32.63M and employs 68 people.
Over the last twelve months the share price has lost 38.1%, trading between 0.37 and 0.77.
Tweenvest scores Medical Developments International Limited across four factors: quality 75/100, value 49/100, growth 70/100. Its strongest factor is quality.
MVP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.63M
- Revenue (TTM)
- $29.45M
- P/E
- 78.32
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 1.56
- 52-week high
- AU$0.77
- 52-week low
- AU$0.37
- Avg volume (3M)
- —
- Shares outstanding
- 112.66M
- Employees
- 68
- Next earnings
- —
About Medical Developments International Limited
Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
- ISIN
- AU000000MVP2
- Founded
- 1972
- Listed since
- Dec 14, 2003
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ImmuPharma plcAIM: IMM | $33.10M | £0.04 | +21.21% |
| biote Corp.NasdaqGM: BTMD | $32.98M | $1.12 | -2.61% |
| Tianda Pharmaceuticals LimitedSEHK: 455 | $32.88M | HK$0.12 | +1.69% |
| Syntara LimitedASX: SNT | $32.88M | AU$0.02 | +14.29% |
| Regent Pacific Group LimitedSEHK: 575 | $32.54M | HK$0.88 | +3.55% |
| PRISM BioLab Co.,LTDTSE: 206A | $32.45M | ¥139.00 | -4.79% |
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | -1.85% |
| MYUNGMOON Pharm co.,LtdKOSE: A017180 | $31.98M | ₩1,286.00 | +1.02% |
Figures last refreshed Oct 11, 2026.